ArticleMethods in molecular biology (Clifton, N.J.)2026
Optimized In Vitro T-Cell Exhaustion Assay for Evaluating T-Cell-Dependent Bispecific Antibodies.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
T-cell exhaustion is characterized by low proliferative capacity, suppressed effector function, and the persistent expression of co-suppressive receptors such as PD-1 and TIM-3. Chronic activation of T cells, as seen in chronic viral infections or cancer, leads to T-cell exhaustion. In addition, T-cell exhaustion is a major obstacle to the clinical application of T-cell-dependent bispecific antibodies (TDBs). On the other hand, blocking the co-suppressive receptors has improved T-cell function, highlighting the importance of recovery from T-cell exhaustion to enhance therapeutic efficacy. Ongoing research focuses on recovering from exhausted T cells using genetic engineering, particularly in CAR-T cell therapy. Although mouse models infected with LCMV are widely used to generate exhausted T cells, this method raises concerns about animal welfare. We established a method using magnetic beads to induce T-cell exhaustion in vitro, simulating the immune state caused by chronic activation. Moreover, this in vitro exhaustion-induction method is applicable to the evaluation of TDB functional activity and the examination of the T-cell manipulation methods. Collectively, the current in vitro T-cell exhaustion assay system will be helpful for the development of TDBs to overcome T-cell exhaustion.
Indexed as
Identifiers
42108349What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.